🇺🇸 FDA
Patent

US 10988538

Bispecific signaling agents and uses thereof

granted A61KA61K2039/505A61K2039/57

Quick answer

US patent 10988538 (Bispecific signaling agents and uses thereof) held by Orionis Biosciences, Inc expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Orionis Biosciences, Inc
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K2039/505, A61K2039/57, A61K38/00, A61K39/395